122 related articles for article (PubMed ID: 25807438)
1. Radioactive iodine labeling of monoclonal antibody against Hsp90α and its use in diagnostic imaging in prostate cancer xenograft model.
Sun HW; Wang RF; Yan P; Zhang CL; Hao P; Ma H; Chen XQ
Eur Rev Med Pharmacol Sci; 2015; 19(5):835-43. PubMed ID: 25807438
[TBL] [Abstract][Full Text] [Related]
2. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
3. 131I-labeled monoclonal antibody targeting neuropilin receptor type-2 for tumor SPECT imaging.
Chen L; Wang L; Yan J; Ma C; Lu J; Chen G; Chen S; Su F; Wang W; Su X
Int J Oncol; 2017 Feb; 50(2):649-659. PubMed ID: 28000859
[TBL] [Abstract][Full Text] [Related]
4. Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma.
Yu M; Zhou H; Liu X; Huo Y; Zhu Y; Chen Y
Ann Nucl Med; 2010 Jan; 24(1):13-9. PubMed ID: 19997991
[TBL] [Abstract][Full Text] [Related]
5. Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.
Liu Z; Zhou X; Shi Y; Du S; Yang Y; Tang J; Shen Y
Cancer Biother Radiopharm; 2011 Apr; 26(2):229-35. PubMed ID: 21510749
[TBL] [Abstract][Full Text] [Related]
6. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging.
Hasegawa Y; Oyama N; Nagase K; Fujibayashi Y; Furukawa T; Murayama Y; Arai Y; Saito S; Welch MJ; Yokoyama O
Nucl Med Biol; 2012 Oct; 39(7):944-7. PubMed ID: 22766258
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
12. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
Zeglis BM; Lewis JS
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741890
[TBL] [Abstract][Full Text] [Related]
13. [Labeling of CDTPA-dianhydride-coupled CD45 monoclonal antibody with yttrium-90].
Fu YB; Li GP; Meng FY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1230-2. PubMed ID: 16939927
[TBL] [Abstract][Full Text] [Related]
14. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
15. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
16. High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.
Verel I; Visser GW; Vosjan MJ; Finn R; Boellaard R; van Dongen GA
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1645-52. PubMed ID: 15290121
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of vascular targeted monoclonal antibody.
Kennel SJ; Huang Y; Zeng WB; Stuckey A; Wall J
Curr Drug Deliv; 2010 Dec; 7(5):428-35. PubMed ID: 20950267
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Radiosynthesis and Metabolism of 131I-Y-c(CGRRAGGSC).
Xie J; Pan D; Lu M; Chen X; Chen Y; Zhang T; Xie Y; Zhou H; Liu L; Yang M; Wang J; Chen D
Anticancer Agents Med Chem; 2017; 17(13):1769-1776. PubMed ID: 28707573
[TBL] [Abstract][Full Text] [Related]
19. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
20. Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody.
Turner CJ; Sykes TR; Longenecker BM; Noujaim AA
Int J Rad Appl Instrum B; 1988; 15(6):701-6. PubMed ID: 3251903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
